anti-TGF-beta RII monoclonal antibody IMC-TR1
Term · Oncology and biomedicine · MLC-T-ONC-011111
A monoclonal antibody directed against transforming growth factor-beta receptor type II (TGF-beta RII) with potential antineoplastic activity. Anti-TGF-beta RII monoclonal antibody IMC-TR1 specifically targets and binds to TGF-beta R11, thereby preventing the activation of TGF-beta RII-mediated signaling pathways. TGF-beta RII is mutated in a number of cancer cell types and is involved in cancer cell proliferation and tumor progression.
| Identifier | MLC-T-ONC-011111 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011111",
"term": "anti-TGF-beta RII monoclonal antibody IMC-TR1",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against transforming growth factor-beta receptor type II (TGF-beta RII) with potential antineoplastic activity. Anti-TGF-beta RII monoclonal antibody IMC-TR1 specifically targets and binds to TGF-beta R11, thereby preventing the activation of TGF-beta RII-mediated signaling pathways. TGF-beta RII is mutated in a number of cancer cell types and is involved in cancer cell proliferation and tumor progression.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1/"
}
Record 2,255 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.